Business GSK, Sanofi to agree $624 million deal with UK...

GSK, Sanofi to agree $624 million deal with UK for COVID-19 vaccine

-

- Advertisment -

GSK, Sanofi to agree $624 million deal with UK for COVID-19 vaccine

 

 

 

 

 

 

 

 

 
British and French pharmaceutical giants, GlaxoSmithKline (GSK) and Sanofi are close to reaching a $624 million (500 million pounds) deal with the United Kingdom (UK) government for the supply of 60 million doses of coronavirus vaccine as many countries move for possible COVID-19 treatments.

Reports suggest that the UK was considering an option to buy the vaccine should the human trials, which are due to commence in September 2020, turn out successful.

The funds would be paid in stages as the vaccine progresses, with the final payment made on delivery.

In order not to be left behind, the UK government has been engaging a wide range of companies both at home and abroad to negotiate access to vaccines. They said that the right announcements of these arrangements will be made as and when agreements with any of these companies are finalized.

The British business ministry’s spokeswoman, who confirmed that the ministry is handling Britain’s supply of potential COVID-19 vaccines, said talks were going on with different parties about access to possible vaccines but didn’t confirm if GSK/Sanofi project was one of them.

According to the ministry official, ‘’The Government’s Vaccines Task Force is actively engaging with a wide range of companies both in the UK and abroad to negotiate access to vaccines.”

“Appropriate announcements of these arrangements will be made as and when agreements with any of these companies are finalized and signed.”

Sanofi is presently working on 2 possible COVID-19 vaccines, one of which uses an adjuvant made by GSK to potentially boost its efficacy. The timeline for its clinical trials is behind the likes of Moderna Inc, the University of Oxford in collaboration with AstraZeneca Plc and an alliance of BioNTech and Pfizer Inc, whose projects all made headlines by moving to human trials as early as March.

Both GSK and Sanofi said that they are placing more priority on quality rather than speed in developing a vaccine.  (Nairametrics)

GSK, Sanofi to agree $624 million deal with UK for COVID-19 vaccine
GSK, Sanofi to agree $624 million deal with UK for COVID-19 vaccine
Parrot Nigeria
An online news aggregator

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest news

Fidelity Bank’s ‘The Payday Revolution’ Is Here

This is indeed a good year to be alive as greater days awaits in Fidelity Bank's 'The Payday Revolution. Register...

How ‘My God’ Killed UNILAG Lecturer Who Demanded Sex From My Daughter – Pastor Wale Oke

        The founder and Presiding Bishop of Christ Life Church Worldwide,  Wale Oke, has claimed that God killed a lecturer...

IGP orders probe into sacking of female cop over pregnancy

The Inspector-General of Police, Mohammed Adamu, has ordered investigation into the sacking of a female corporal, Olajide Omolola, over...

Fed Govt got N2.94tr non-oil income in 2020

            The Federal Government earned N2.94 trillion as non-oil income in 2020 with transportation and haulage accounting for nearly half...

Makinde asks Buhari for more riot policemen

              Oyo State needs more deployment of riot policemen and a full support of the Federal Government for its joint...

FG evacuates 802 Nigerians from Saudi Thursday, Friday

THE Ministry of Foreign Affairs has disclosed that 802 Nigerians will return from Saudi Arabia on Thursday and Friday. The...

TRENDING

JUST IN: Nollywood actor Ernest Asuzu dies

            Veteran Nollywood actor Ernest Asuzu is dead. He died on...

BREAKING: Finally, Buhari fires service chiefs

          President Muhmmadu Buhari has fired the service chiefs and...
- Advertisement -

You might also likeRELATED
Recommended to you